Objective: This study aimed to investigate whether polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) gene are associated with age at menarche and age at natural menopause in white women.
M enarche and menopause are two key physiological events in female life, which mark, respectively, the lower and upper limits of a reproductive period. In addition to this, the onsets of menarche and menopause affect female well-being in later life. In particular, early age at menarche (AM) was associated with the higher risk for endometrial, 1 breast, 2,3 and ovarian 4, 5 cancers, psychological problems, 6 and obesity, 7, 8 whereas later menarche may increase the risk of osteoporosis 9,10 and preeclampsia. 11 Age at natural menopause (ANM) is associated with numerous postmenopausal health problems, including osteoporosis, 12, 13 cardiovascular disease, 14 and ovarian, 15, 16 breast, 17 and endometrial cancers, 18 to name a few. Therefore, identifying the factors that determine AM and ANM may potentially help in preventing these health complications.
Both AM and ANM are complex traits and are thus determined by multiple environmental and genetic factors as well as their interactions. 19<21 Various studies estimate a contribution of genetic factors to the variation of these traits approximately 45% to 74% for AM 22<24 and 63% to 74% 22, 25 for ANM.
Research on genetic factors underlying AM and ANM has attracted an increased interest in recent years. As a result, several genes and genomic regions were reported as the candidates. 26 /29 The methylenetetrahydrofolate reductase (MTHFR) gene may be a potential addition to this list. This gene encodes for an enzyme, which catalyzes irreversible reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a substrate for homocysteine remethylation to methionine. The biological role of the encoded protein is likely to be related to its involvement in homocysteine metabolism. Individuals who carry missense mutations, which result in the decreased activity of the enzyme, develop severe hyperhomocystinemia, homocystinuria, motor dysfunction, and various neurological and vascular problems. 30 Plasma homocysteine levels are affected by menses and menopause 31<33 and may also be influenced by the MTHFR polymorphisms. 34, 35 Folate was shown to have a modulatory effect on carcinogenesis. 36 A common polymorphism of the MTHFR gene, C677T (rs1801133), was suggested to play a role in susceptibility of women to various cancers of the reproductive organs, namely, cervical, 37,38 ovarian, 39 breast, 39, 40 and endometrial. 41, 42 The T allele of this polymorphism was also implicated in the increased fracture risk in postmenopausal women. 43, 44 All these data suggest that the MTHFR gene may be associated with AM and/or ANM.
In the present study, we analyzed six single nucleotide polymorphisms (SNPs) for their probable association with these traits.
METHODS

Participants
All participants came from our previous studies. 45, 46 The protocol of the present study was approved by the institutional review board of Creighton University. Information about the following reproductive history and lifestyle factors was collected from the participants through a nurse-administered questionnaire: number of pregnancies, length of breast-feeding, smoking and alcohol consumption habits, and use of hormonal contraceptives. Informed consent was obtained from each study participant before entering the project. The exclusion criteria for the participants were detailed elsewhere. 47 In brief, they included, among others, chronic diseases of vital organs (brain, lung, heart, liver, kidney), systemic metabolic diseases (diabetes, hypoparathyroidism and hyperparathyroidism, hyperthyroidism, etc), and malnutrition conditions (chronic diarrhea, chronic ulcerative colitis, etc). The assessment of the exclusion criteria was conducted through nurse-administered questionnaires and/or medical records. Women with ANM younger than 40 years were also excluded from the analyses as probably having experienced premature ovarian failure. A total of 305 otherwise healthy white women of European origin were included in the study. For the association analysis of AM and ANM, two subsamples of unrelated women (305 and 210 participants, respectively) were selected from the total sample. The size of the ANM sample was smaller because of the exclusion of women with surgical menopause.
AM was defined as the age of first menstrual bleeding less the birth date (in years rounded to the 10th decimal); ANM was calculated as the age at the last menstrual period (years) followed by 12 consecutive months without menses. The data about the participant samples are given in Table 1 .
Genotyping
Genomic DNA was isolated from blood buffy coat using a commercial kit (Gentra Systems, Inc., Minneapolis, MN). The SNPs were genotyped using Integrated BeadArray System (Illumina Inc.).
Statistical analyses
The W 2 test was applied to check the Hardy-Weinberg equilibrium of all SNPs. In addition, mendelian consistency of genotype data was verified using PedCheck. 48 The effects of the lifestyle factors and the MTHFR gene polymorphisms on AM and ANM were estimated by linear regression models.
For two SNPs, rs2066470 and rs17037390, the minor allele homozygotes were of too low frequencies, so that they were combined with heterozygotes in a single group. In such a case, two groups (with or without the minor allele) were analyzed instead of the three (minor allele homozygote, heterozygote, and major allele homozygote). The participants were also categorized according to the number of pregnancies and months of breast-feeding ( Table 1) .
The association of the SNPs and lifestyle factors with AM and ANM was examined by both stepwise multiple regression and univariate analysis of variance. In the univariate analysis, each marker was investigated independently. The analyses were performed using SPSS (v. 16.0.1, SPSS Inc., Chicago, IL) and the PLINK software, 49 available at http://pngu.mgh.harvard.edu/~purcell/plink/.
RESULTS
Study participants' characteristics
The total sample used in the study consisted of 305 women. The mean (TSD) AM of the participants was 13.0 (T0.1) years, and the mean (TSD) ANM was 46.0 (T0.4) years. The relatively low ANM in the total sample was due to the inclusion of women with surgical menopause. The age at surgical menopause for this population is approximately 40 years. 50 The ANM in the subsample of postmenopausal women was higher (49.4 T 0.3 y; Table 1 ) but still lower than the average ANM for the US female population (approximately 51 y). This may be due to the interpopulation differences in ANM across the United States. On the other hand, the median ANM (50 y) of our subsample was very similar to the mean ANM for the US female population. The parameters of skewness and kurtosis of the ANM for the subsample were j0.020 T 0.169 and 0.830 T 0.337, respectively. The former falls within the range of normal distribution; the latter slightly deviates from that. Altogether, these results suggested that our sample was not biased.
The multiple regression analysis showed that among the lifestyle factors considered, smoking (P = 0.03), alcohol consumption (P = 0.03), and length of breast-feeding (P = 0.03) had significant effect on ANM in this sample ( Table 2) . These variables were used as covariates in the subsequent association analysis. No lifestyle factors were used as covariates for the AM association analyses because they all occurred presumably after menarche. Length of breast-feeding seems to be a highrisk factor for earlier natural menopause: women having breast-fed for more than 1 year have approximately 2.2 times (95% CI, 1.1-4.6) higher risk to pass menopause before the average ANM for the population, that is, 49 years, than those who have never breast-fed. All studied polymorphisms indicated no deviation from Hardy-Weinberg equilibrium ( Table 3) .
SNP association analyses
The analyses did not reveal any association between the individual SNPs of the MTHFR gene and AM. However, three significant pairwise SNP interactions were determined: SNP1/ SNP4 (P = 0.02), SNP1/SNP6 (P = 0.02), and SNP2/SNP6 (P = 0.04).
Similar to AM, no association between the individual MTHFR polymorphisms and ANM was determined. Interaction effects between the SNPs were not detected either. However, several haplotypes were found to be significantly associated with ANM (Table 4 ). Interestingly, all these haplotypes included SNP4 (rs1476413) located in an intron of MTHFR. An average contribution of each haplotype to the overall variation of ANM in the studied population is ap-proximately 2% (Table 4 ; coefficient R 2 ). Some haplotypes (eg, A and C) are quite common in the population. The rarest haplotypes (B and D) seem to be associated with the lowest ANM: their carriers enter menopause, on average, approximately 2.7 years earlier than the noncarriers (Table 4 ; coefficient A).
Several SNPs indicated significant interaction with some lifestyle factors (Table 5 ). Specifically, both SNP1 and SNP2 showed interaction with smoking, length of breast-feeding, and AM. SNP3, which results in a common replacement of alanine with valine in position 222 of the respective protein, indicates nearly significant interaction with smoking and duration of breast-feeding. Overall, the MTHFR gene seems to strongly mediate the effect on the lifestyle factors on ANM.
DISCUSSION
The present study first reports possible effects of the MTHFR gene on AM and ANM. These effects are of a different nature. Although no direct association of any independent SNP with the above traits was determined, several haplotypes associated with ANM plus several SNP-SNP and SNP-environment interaction effects on the traits were identified.
Principal health implications for the MTHFR gene are based on its key role in folate and homocysteine metabolism as well as DNA synthesis. Therefore, the MTHFR gene has been a subject of numerous studies for possible association of its polymorphisms with various disorders, particularly those associated with folate and homocysteine status. 51/53 Among all known SNPs of the MTHFR gene, two replacement polymorphisms, C677T (rs1801133, SNP3) and A1298C (rs1801131), have been most commonly used as the markers in the previously mentioned studies. The CYT substitution at position 677 (and AlaYVal replacement at amino acid 222, respectively) results in a thermolabile enzyme with reduced activity. 54 Recently, direct association of this allele with low plasma folate level was reported. 55 Some evidence that this polymorphism is associated with a number of postmenopausal disorders, including osteoporosis 43, 56 and Alzheimer disease, exists. 57 Further support for the possible association of the MTHFR gene with AM and ANM comes from the data on the effect of menses and menopause on plasma homocysteine status. Although there is no direct evidence about the influence of menarche on plasma homocysteine level (simply because of the lack of such studies), several studies reported that this level significantly varies between the phases of the menstrual cycle. 32, 33 In turn, menopause was shown to decrease plasma homocysteine concentration. 31 ,58<60 Also, folate and homocysteine were implicated in human reproductive health and, in particular, subfertility. 61, 62 In addition to menopause, plasma homocysteine level is elevated by various environmental factors, including smoking, 63 alcohol intake, 64 and breast-feeding, 65, 66 which all were shown to influence ANM ( Table 2 ). Our results indicate that the MTHFR polymorphisms probably interact with the previously mentioned environmental factors in their effect on ANM ( Table 5 ). The mechanism of this interaction is unknown, but it is likely to be related to the maintenance of plasma homocysteine and folate status. The previously reported data about an interaction effect of alcohol with the C677T polymorphism on total plasma homocysteine level 67 are in further support of this assumption. On the other hand, it should be noted that the data about smoking and alcohol consumption used in the present study did not specify the dose and duration of these factors. Therefore, the obtained results on interaction of the MTHFR polymorphisms with these lifestyle factors may be biased to some extent.
There is increased evidence that health problems, which are associated with AM or ANM, may have a shared genetic basis with these traits. For example, late menarche is a known risk factor for low bone mass. 68 A recent study by Guo et al 19 suggested that the observed significant phenotypic correlation between bone mineral density (BMD) and AM is likely determined by shared genetic factors. Later, Pan et al 29 identified several genomic regions that may harbor genes contributing to both osteoporosis and menarche. Likewise, such shared regions were also determined for BMD and ANM. 69 There are also ample data about the association of BMD candidate genes with AM and ANM. 50,70<73 The MTHFR gene may be an addition to this list because it was previously reported to contribute to BMD and higher risk of fractures. 43, 74 The question whether AM and ANM have shared a genetic basis remains unresolved. Some studies report positive phenotypic correlation between these traits, 75, 76 whereas others do not. 22, 77 Results of genetic linkage and association studies suggest that this basis may be shared partially. Specifically, several genomic regions were reported to harbor quantitative trait loci differently for AM and ANM, 27,78<80 whereas one region, 11q23, was identified as being linked to both AM 27 and ANM. 28 Also, several genes seem to be associated with both of these traits. 81<83 Our results on the potential contribution of MTHFR to AM and ANM provide further support for the shared genes for both traits. However, to what extent this basis is shared needs further investigation.
Several caveats for our findings should also be acknowledged. First, our study has limited statistical power to detect interactions because of the small sample size; therefore, the observed significant interactions should be treated with caution. Second, six SNPs and several lifestyle factors were analyzed, which may raise a multiple testing problem. Although adjustments for multiple testing are rare in studies in which a modest number of candidate markers are genotyped, this may nonetheless result in a risk of false discoveries. On the other hand, in our study, all six SNPs in the MTHFR gene were in high linkage disequilibrium, and tests were highly correlated. Thus, the risk of false discoveries seems to be small. In such a case, simple correction for multiple testing may result in further decrease of power to detect real effects.
CONCLUSIONS
This study first reports a possible effect of the MTHFR gene on timing of menarche and menopause. In addition to the well-known missense functional polymorphism, C677T (rs1801133), several other nonreplacement nucleotide polymorphisms, which may be associated with AM and/or ANM, were identified. Further replication studies in independent samples of larger scale and different ethnicities are needed to validate the results of the present study and to better understand the relationships between the MTHFR gene and onset of menarche and menopause.
